EPO and autoimmune hepatitis: In addition, mean baseline EPO on the AIH day was not significantly different from mean baseline EPO on the control day (12.43 mIU/mL [8.65, 16.21] vs. 10.78 mIU/mL [7.95, 13.62]; p = 0.15) (Figure 3).